2nd Quarter - Report
ORGANOGENESIS INC. for ORGANOGENESIS INC.
Firm
Client
Income
—
Expenses
$60,000
Expense method
C: businesses, Internal Revenue Code section 162(e)
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Food and Drug Administration policy on chronic wound healing products
| Lobbyist | Covered position, as disclosed |
|---|---|
| ARTHUR-PAUL PETROSINELLI | — |
Veterans VET
Procurement of chronic wound healing products
| Lobbyist | Covered position, as disclosed |
|---|---|
| ARTHUR-PAUL PETROSINELLI | — |
Medicare/Medicaid MMM
Medicare reimbursement policy for chronic wound healing products
| Lobbyist | Covered position, as disclosed |
|---|---|
| ARTHUR-PAUL PETROSINELLI | — |
Defense DEF
Federal research and development funding regarding regenerative medicine products
| Lobbyist | Covered position, as disclosed |
|---|---|
| ARTHUR-PAUL PETROSINELLI | — |
Taxation/Internal Revenue Code TAX
Medical device excise tax H.R.2207 and S.692 (Protect Medical Innovation Act of 2019), all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| ARTHUR-PAUL PETROSINELLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.